The thymus in myasthenia gravis. Evidence for altered cell populations.
D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D002478:Cells, Cultured; D003165:Complement System Proteins; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007104:Immune Adherence Reaction; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007958:Leukocyte Count; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008875:Middle Aged; D008934:Mitogens / Q000494:pharmacology; D008937:Mitomycins / Q000494:pharmacology; D009157:Myasthenia Gravis / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D013945:Thymoma / Q000276:immunology; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology* / Q000473:pathology; D013952:Thymus Hyperplasia / Q000276:immunology / Q000473:pathology; D013953:Thymus Neoplasms / Q000276:immunology
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008934:Mitogens; D008937:Mitomycins; D003165:Complement System Proteins